Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000037226 | SCV000060883 | benign | not specified | 2012-03-19 | criteria provided, single submitter | clinical testing | p.Ala38Ala in Exon 01 of DES: This variant is not expected to have clinical sign ificance because it does not alter an amino acid residue, is not located within the splice consensus sequence and has been identified in 0.6% (22/3452) of Afric an American chromosomes from a broad population by the NHLBI Exome Sequencing Pr oject (http://evs.gs.washington.edu/EVS;). |
Eurofins Ntd Llc |
RCV000037226 | SCV000202609 | benign | not specified | 2016-02-22 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000037226 | SCV000235776 | benign | not specified | 2014-06-26 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV000464462 | SCV000562354 | benign | Desmin-related myofibrillar myopathy | 2024-01-25 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV001171065 | SCV001333735 | benign | Cardiomyopathy | 2018-04-10 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002453311 | SCV002617677 | likely benign | Cardiovascular phenotype | 2019-09-29 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002490504 | SCV002794926 | likely benign | Dilated cardiomyopathy 1I; Desmin-related myofibrillar myopathy; Neurogenic scapuloperoneal syndrome, Kaeser type | 2021-08-27 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000037226 | SCV004038080 | benign | not specified | 2023-08-19 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003944905 | SCV004757824 | likely benign | DES-related condition | 2020-02-10 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Clinical Genetics, |
RCV000037226 | SCV001923873 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001705670 | SCV001928191 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001705670 | SCV001970133 | likely benign | not provided | no assertion criteria provided | clinical testing |